Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds B of A Securities Downgrades Vontier to Neutral

B of A Securities Downgrades Vontier to Neutral

B of A Securities analyst Andrew Obin downgrades Vontier (NYSE:VNT) from Buy to Neutral.

byBenzinga Newsdesk

December 12, 2022

1 minute read

B of A Securities analyst Andrew Obin downgrades Vontier (NYSE:VNT) from Buy to Neutral.

General
News

Nissan Bumps Up Global EV Targets – What’s On The Cards Now?

By Shivani Kumaresan

February 27, 6:53 AM

Nissan Motor Co Ltd (OTC:NSANY) has raised its global electric vehicle goals to reflect changes in customer needs and to accelerate…

NSANY

Tesla, Adobe And 2 Other Stocks Insiders Are Selling

By Lisa Levin

October 6, 9:09 AM

Silver futures traded slightly higher this morning on Thursday. Investors, meanwhile, focused on some notable insider trades.

ADBE

Telsey Advisory Group Reiterates Market Perform on Stitch Fix, Maintains $5 Price Target

By Benzinga Newsdesk

February 27, 6:09 AM

Telsey Advisory Group analyst Dana Telsey reiterates Stitch Fix (NASDAQ:SFIX) with a Market Perform and maintains $5 price target.

SFIX

News

Castle Biosciences Receives Accreditation From The College Of American Pathologists For Its Pittsburgh Clinical Laboratory

By Benzinga Newsdesk

November 21, 8:09 AM

Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today announced that the Accreditation Committee of the College of American Pathologists (CAP) has

CSTL

B of A Securities Downgrades Vontier to Neutral

Related Posts

Nissan Bumps Up Global EV Targets – What’s On The Cards Now?

Tesla, Adobe And 2 Other Stocks Insiders Are Selling

Telsey Advisory Group Reiterates Market Perform on Stitch Fix, Maintains $5 Price Target

Castle Biosciences Receives Accreditation From The College Of American Pathologists For Its Pittsburgh Clinical Laboratory